NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Eigen Therapeutics

Eigen Therapeutics

Private
Redwood City, CaliforniaHealthcare & Life Scienceshttps://www.eigentx.com/

Last Round

Seed

Mar 5, 2024

Total Funding Raised

$7M

Company Overview

Eigen Therapeutics is a biotechnology company that develops AI-enabled priming therapies designed to address cancer heterogeneity and enhance the effectiveness of targeted oncology treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

drug discoveryAI drug discoverytargeted oncologypriming therapiesantibody-drug conjugatesADCradioligand therapiestumor heterogeneitycombinatorial screeningrobotic automationprecision medicinebiotech discovery platformin silico drug discoverylab automationbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eigen Therapeutics Comparables

Compare Eigen Therapeutics with similar companies based on industry and business-model similarity.

Eigen Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TenSixty Bio
75%
Olio Labs
74%
Pathway Bio
68%

Eigen Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 5, 2024
SeedDec 8, 2022

Key People

Founding team and executive leadership

Kamran A.

CTO Co-Founder

Founding Team

Transon Nguyen

CEO & Co-Founder

Founding Team

Omid Karkouti

COO

Executive Team

Eigen Therapeutics Investors

Notable investors and investment history

Eigen Therapeutics investors
InvestorRounds
Builders VCSeed
SeaX VenturesSeed
Mount Pleasant VenturesSeed
Hawktail ManagementSeed
ZAKA VCSeed
BiovergeSeed
First Round CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 8, 2022

    $7M round led by First Round Capital.

Eigen Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Eigen Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Eigen Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersRedwood City, California
Employee Range4
Year Founded2021
Last FundingMar 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.